Additional File 4 of the Relationship Between Menopausal Syndrome and Gut Microbes

Yaqian Liu,Ying Zhou,Ting Mao,Yanmei Huang,Jingtao Liang,Min Zhu,Peixun Yao,Yun Zong,Jianying Lang,Yingxuan Zhang

DOI: https://doi.org/10.6084/m9.figshare.21523827

2022-01-01

Abstract:Additional file 4. KEGG level3 pathways of functional prediction. 50 KEGG level3 pathways enriched in the P group were found to be significantly higher than in H group.

What problem does this paper attempt to address?

The Relationship Between Menopausal Syndrome and Gut Microbes

Yaqian Liu,Ying Zhou,Ting Mao,Yanmei Huang,Jingtao Liang,Min Zhu,Peixun Yao,Yun Zong,Jianying Lang,Yingxuan Zhang

DOI: https://doi.org/10.1186/s12905-022-02029-w

2022-01-01

Abstract:Background Gut microbes were closely related to women’s health. Previous studies reported that the gut microbes of premenopausal women were different from those of postmenopausal women. However, little was known about the relationship between gut microbiota dysbiosis and menopausal syndrome (MPS). The aim of this study was to explore the relationship between MPS and gut microbes. Methods Patients with MPS (P group, n = 77) and healthy women (H group, n = 24) at menopause were recruited in this study. The stool specimen and clinical parameters (demographic data, follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), et al) of participants’ were collected. We evaluated the differences in gut microbes by 16S ribosomal RNA gene sequencing. We used LEfSe to identify gut microbes with varying abundances in different groups. The Spearman correlation coefficients of clinical parameters and gut microbes were calculated. PICRUSt was used to predict the potential KEGG Ortholog functional profiles of microbial communities. Results The abundance of 14 species differed substantially between the MPS and menopausal healthy women (LDA significance threshold > 2.0) according to LEfSe analysis. Using Spearman’s correlation analysis, it was discovered that E2 had a positive correlation with Aggregatibacter segnis, Bifidobacterium animalis, Acinetobacter guillouiae ( p < 0.05, these three species were enriched in menopausal healthy women), while FSH and LH had a negative correlation with them ( p < 0.05). KEGG level3 metabolic pathways relevant to cardiovascular disease and carbohydrate metabolism were enriched in the MPS ( p < 0.05), according to functional prediction by PICRUST and analyzed by Dunn test. Conclusion There was gut microbiota dysbiosis in MPS, which is reflected in the deficiency of the abundance of Aggregatibacter segnis , Bifidobacterium animalis and Acinetobacter guillouiae related to the level of sex hormones. In MPS individuals, species with altered abundances and unique functional pathways were found.
Additional File 5 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Hua Zha,Daiqiong Fang,Aimee Van Der Reis,Kevin Chang,Liya Yang,Jiao-Jiao Xie,Ding Shi,Qiaomai Xu,Lanjuan Li

DOI: https://doi.org/10.6084/m9.figshare.12441257

2020-01-01

Abstract:Additional file 5:Figure S1. Co-occurrence network inference analysis determines the bacterial correlations in each of the seven groups.
Additional File 3 of Vegetarian Diet Duration’s Influence on Women’s Gut Environment

Xinqi Deng,Jiangtao Si,Yonglong Qu,Jie Liu,Yingkun He,Chun-Guo Wang,Yuping Zhang

DOI: https://doi.org/10.6084/m9.figshare.16726786

2021-01-01

Abstract:Additional file 3. Table S2. WGCNA MICROBIOTA MODULE.
Systematic Review and Meta-analysis: Changes of Gut Microbiota before and after Menopause

Meina Yang,Shu Wen,Jing Zhang,Jin Peng,Xiaoyang Shen,Liangzhi Xu

DOI: https://doi.org/10.1155/2022/3767373

2022-07-26

Disease Markers

Abstract:Objective. To systematically evaluate the differences in intestinal flora before and after menopause. To provide a possible mechanism for perimenopausal syndrome and provide a basis for probiotics as adjuvant therapy. Methods. MEDLINE, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), CNKI, Wanfang, and VIP databases were searched. The included studies were case-control studies. Results. Three case-control studies were included, with a total of 156 people. At the phylum level, there were no differences between premenopausal and postmenopausal women. At the genus level, the relative abundances of A. odoratum and B. cholerae were higher in postmenopausal women than in premenopausal women, with no differences among other genera. The Shannon diversity index increased after menopause, but no differences were found. Only one study found a positive association of estradiol with Gammaproteobacteria and Myxococcales and a negative association with Prevotellaceae. Conclusions. On the basis of previous studies, it was found that there was no significant difference at the phylum level between postmenopausal women and premenopausal women, but Odoribacter and Bilophila increased at the genus level in postmenopausal women. The class of Gammaproteobacteria may be positively correlated with estradiol. Limited by the number of included studies, more high-quality clinical studies are needed for validation.

genetics & heredity,pathology,medicine, research & experimental,biotechnology & applied microbiology
Additional File 8 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Hua Zha,Daiqiong Fang,Aimee Van Der Reis,Kevin Chang,Liya Yang,Jiao-Jiao Xie,Ding Shi,Qiaomai Xu,Lanjuan Li

DOI: https://doi.org/10.6084/m9.figshare.12441272

2020-01-01

Abstract:Additional file 8:Figure S4. Brief schematic diagram of the experimental design.
Study on gut microbiota and metabolomics in postmenopausal women

Xinyuan Xie,Jinbin Song,Yue Wu,Mei Li,Wenfeng Guo,Shuang Li,Yanwu Li

DOI: https://doi.org/10.1186/s12905-024-03448-7

2024-11-23

BMC Women s Health

Abstract:Menopausal syndrome, occurring during the menopausal stage in women, manifests as symptoms stemming from decreased estrogen levels, such as hot flashes, insomnia, mental disorders (anxiety, depression), and osteoporosis. The bulk of studies have indicated alterations in the gut microbiota of those experiencing menopause syndrome compared to healthy women. However, This article focuses on the alterations in gut microbiota in perimenopausal women. Our study utilized 16 s rRNA sequencing to determine the differences in the gut microbiota and metabolites among 44 menopausal syndrome women. The distribution of gut microbiota in postmenopausal women varies based on the level of follicle stimulating hormone, with changes in gut microbiota abundance taking precedence over symptom onset. Fecal metabolites reveal changes in several metabolites, including Amino acid metabolism (Tyrosine, Tryptophan), Lipid metabolism (Alpha linolenic acid metabolism), and other metabolites. Disturbances in lipid metabolism, triggered by hormonal level fluctuations, can contribute to the development of osteoporosis.

public, environmental & occupational health,obstetrics & gynecology
The Menopause-Related Gut Microbiome: Associations with Metabolomics, Inflammatory Protein Markers, and Cardiometabolic Health in Women with HIV.

Yi Wang,Anjali Sharma,Kathleen M. Weber,Elizabeth Topper,Allison A. Appleton,Deborah Gustafson,Clary B. Clish,Robert C. Kaplan,Robert D. Burk,Qibin Qi,Brandilyn A. Peters

DOI: https://doi.org/10.1097/gme.0000000000002287

2024-01-01

Abstract:OBJECTIVE:This study aimed to identify menopause-related gut microbial features, as well as their related metabolites and inflammatory protein markers, and link with cardiometabolic risk factors in women with and without HIV.METHODS:In the Women's Interagency HIV Study, we performed shotgun metagenomic sequencing on 696 stool samples from 446 participants (67% women with HIV), and quantified plasma metabolomics and serum proteomics in a subset (~86%). We examined the associations of menopause (postmenopausal vs premenopausal) with gut microbial features in a cross-sectional repeated-measures design and further evaluated those features in relation to metabolites, proteins, and cardiometabolic risk factors.RESULTS:Different overall gut microbial composition was observed by menopausal status in women with HIV only. We identified a range of gut microbial features that differed between postmenopausal and premenopausal women with HIV (but none in women without HIV), including abundance of 32 species and functional potentials involving 24 enzymatic reactions and lower β-glucuronidase bacterial gene ortholog. Specifically, highly abundant species Faecalibacterium prausnitzii , Bacteroides species CAG:98 , and Bifidobacterium adolescentis were depleted in postmenopausal versus premenopausal women with HIV. Menopause-depleted species (mainly Clostridia ) in women with HIV were positively associated with several glycerophospholipids, while negatively associated with imidazolepropionic acid and fibroblast growth factor 21. Mediation analysis suggested that menopause may decrease plasma phosphatidylcholine plasmalogen C36:1 and C36:2 levels via reducing abundance of species F. prausnitzii and Acetanaerobacterium elongatum in women with HIV. Furthermore, waist-to-hip ratio was associated with menopause-related microbes, metabolites, and fibroblast growth factor 21 in women with HIV.CONCLUSIONS:Menopause was associated with a differential gut microbiome in women with HIV, related to metabolite and protein profiles that potentially contribute to elevated cardiometabolic risk.
Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Xueying Liu,Kejing Zhu,Renke He,Zhaoying Jiang,Haiyan Wu,Jiaen Yu,Qinyu Luo,Jianzhong Sheng,Jiexue Pan,Hefeng Huang,Zhongliang Lin

DOI: https://doi.org/10.21203/rs.3.rs-4188266/v1

2024-01-01

Abstract:Abstract Background Previous studies have reported an association between gut microbial dysbiosis and ovarian diseases, however, it is not clear whether a causal association exists. Methods Two-sample Mendelian randomization (MR) analysis was performed to genetically predict the causal effects of the gut microbiota on polycystic ovary syndrome (PCOS), premature ovarian failure (POF), ovarian endometriosis, and malignant and benign ovarian neoplasms. The inverse variance weighted (IVW) method was used as the primary statistical method. A series of sensitivity analyses, including weighted median, MR-Egger, simple mode, weighted mode methods, MR pleiotropy residual sum and outlier (MR-PRESSO) and leave-one-out analysis, were also conducted to assess the robustness of the MR analysis results. Reverse MR analysis was implemented to explore whether ovarian diseases have any causal impact on the bacterial genera. Additionally, the Cochran’s Q test was used to evaluate heterogeneity among instrumental variables. Results IVW analysis revealed that several bacteria were associated with decreased risk of PCOS, POF, ovarian endometriosis, and benign and malignant ovarian neoplasm. Moreover, several bacteria were the causes of increased risks for POF, ovarian endometriosis, and benign and malignant ovarian neoplasm, respectively. Reverse MR analysis did not reveal a significant causal effect of these ovarian diseases on the gut microbiota. These findings were robust according to extensive sensitivity analyses. Conclusion Our results provide genetic evidence to support the causal relationship between specific gut microbiota taxa and ovarian diseases; thus, the gut microbiota should be considered a preventative strategy for ovarian diseases.
Integrated analysis of metabolome and microbiome in a rat model of perimenopausal syndrome

Yanqiu Wei,Juanjuan Shi,Jianhua Wang,Zongyan Hu,Min Wang,Wen Wang,Xiujuan Cui

DOI: https://doi.org/10.1128/msystems.00623-24

2024-10-22

mSystems

Abstract:ABSTRACT The objectives of this study are to examine the disparities in serum and intestinal tissue metabolites between a perimenopausal rat model and control rats and to analyze the diversity and functionality of intestinal microorganisms to determine the potential correlation between intestinal flora and metabolites. We established a rat model of perimenopausal syndrome (PMS) and performed an integrated analysis of metabolome and microbiome. Orthogonal partial least-squares discriminant analysis scores and replacement tests indicated distinct separations of anion and cation levels between serum and intestinal samples of the model and control groups. Furthermore, lipids and lipid-like molecules constituted the largest percentage of HMDB compounds in both serum and intestinal tissues, followed by organic acids and derivatives, and organoheterocyclic compounds, with other compounds showing significant variability. Moreover, analysis of diversity and functional enrichment of the intestinal microflora and correlation analysis with metabolites revealed significant variability in the composition of the intestinal flora between the normal control and perimenopausal groups, with these differentially expressed intestinal flora strongly correlated with their metabolites. The findings of this study are expected to contribute to understanding the indications and contraindications for estrogen application in perimenopausal women and to aid in the development of appropriate therapeutic agents. IMPORTANCE In this work, we employed 16S ribosomal RNA gene sequencing to analyze the gut microbes in stool samples. In addition, we conducted an ultra-high-performance liquid chromatography-tandem mass spectrometry-based metabolomics approach on gut tissue and serum obtained from rats with perimenopausal syndrome (PMS) and healthy controls. By characterizing the composition and metabolomic properties of gut microbes in PMS rats, we aim to enhance our understanding of their role in women’s health, emphasizing the significance of regulating gut microbes in the context of menopausal women’s well-being. We aim to provide a theoretical basis for the prevention and treatment of PMS in terms of gut microflora as well as metabolism.

microbiology
Additional File 2: of Linking Gut Microbiota, Metabolic Syndrome and Economic Status Based on a Population-Level Analysis

Yulong He,Wei Wu,Shan Wu,Huimin Zheng,Li Pan,Haoyue Sheng,Mu-Xuan Chen,Zihui Chen,Guiyuan Ji,Zuoping Zheng,Prabhakar Mujagond,Xiaojiao Chen,Zuhua Rong,Peng Chen,Li-Yi Lyu,Xian Wang,Jiabao Xu,Chong-Bin Wu,Nan Yu,Yanjun Xu,Jie Yin,Jeroen Raes,Wenjun Ma,Hongwei Zhou

DOI: https://doi.org/10.6084/m9.figshare.7126217

2018-01-01

Abstract:Supplementary Tables S1-S13.Â (XLSX 1996 kb)
Vaginal microbiota, menopause, and the use of menopausal hormone therapy: a cross-sectional, pilot study in Chinese women

Yibing Lan,Bihui Jin,Yue Zhang,Yizhou Huang,Zhou Luo,Chang Su,Jingjing Li,Linjuan Ma,Jianhong Zhou

DOI: https://doi.org/10.1097/GME.0000000000002432

2024-09-03

Menopause

Abstract:Objective: To compare the vaginal microbiota of premenopausal and postmenopausal women and postmenopausal women undergoing menopausal hormone therapy (MHT) and examine the association between vaginal microbiota and genitourinary syndrome of menopause (GSM). Methods: This cross-sectional study classified 94 women aged 40 to 60 years into three groups: premenopausal (Pre, n = 32), postmenopausal (Post, n = 30), and postmenopausal women who received MHT orally (Post + MHT, n = 32). Neither the Pre nor the Post group received hormone therapy within the past 6 months. Postmenopausal women who received vaginal MHT were not included. Vaginal swabs were obtained, and microbial composition was characterized by 16S rRNA gene sequencing targeting the V3 to V4 region. Clinical data were collected and serum sex hormones were measured. The most bothersome symptom approach and vaginal health index were used to evaluate GSM. Mann-Whitney U or Kruskal-Wallis ANOVA followed by multiple comparison tests were performed for comparison between or across groups. The correlations between GSM symptom scores and vaginal microbiota were determined using Spearman's correlation analysis. Results: The vaginal community of postmenopausal women was characterized by a decreased abundance of Lactobacillus (Post 18% vs Pre 69%); an increased abundance of several anaerobic bacteria, including Prevotella, Escherichia-Shigella, and Bifidobacterium; and a higher microbial diversity (P < 0.001 for Shannon and Simpson indexes) than those of premenopausal women. The vaginal community of postmenopausal women who received MHT had an increased abundance of Lactobacillus (54%) and lower microbial diversity (P < 0.001 for Shannon and Simpson indexes) than the postmenopausal women. The vaginal microbial community composition of the Pre group shared more similarity with that of the Post + MHT group (Adonis P = 0.051) than with that of the Post group (Adonis P < 0.001). A decreased abundance of Lactobacillus and high diversity in the vaginal community were found in women with moderate to severe GSM symptoms. Conclusions: Among Chinese postmenopausal women, those receiving MHT had higher Lactobacillus abundance but lower abundance of diverse anaerobes and diversity of the vaginal microbial community compared to non-MHT women. MHT in postmenopausal women may potentially contribute to reestablishing vaginal microbiota homeostasis. Findings in this pilot study, however, need to be examined in larger, prospective studies.
Sex, age and menopause differentially impact gut barrier function and proteomic profile

Christina Hoyer-Kimura,Christina Hoyer-Kimura,Paul Langlas,Marissa Lopez-Schultz,Victoria Salcedo,Joshua Fricks,John Konhilas

DOI: https://doi.org/10.1152/physiol.2023.38.s1.5735182

IF: 11.8461

2023-05-01

Physiology

Abstract:Cardiovascular disease (CVD) and metabolic syndrome (MetS) depends on sex, age and hormonal status and is worsened by comprised gut barrier function. Previous work establishes that loss of estrogen and age comprises intestinal barrier function permeability exacerbating systemic inflammation, increasing gut oxidative stress, and elevating pro-inflammatory cytokines. We hypothesize that loss of estrogen during menopause underlies sex- and age-dependent pathological remodeling in gut barrier function leading to increased risk for CVD and MetS. C57BL-6 male and female mice were fed a high-fat-diet (HFD, 45% fat); menopause was induced via 21 days of 4-vinylcycohexane diepoxide (VCD) intraperitoneal injections (controls were injected with sesame oil) in adult and aged female mice. Diestrus was reached 14+days after the end of VCD injections and menopause was determined by cytology. Upon sacrifice, plasma was collected, and intestines were flash frozen. LPS assays were performed on plasma samples of premenopausal (n=8), menopausal (n=10), aged menopausal (n=6), and male mice (n=11). Male mice, and aged menopausal mice had significantly higher circulating endotoxin levels than premenopausal mice, while menopausal mice did not significantly differ from pre-menopause. These results indicate that age and sex impact barrier leakiness. Further, these results highlight that barrier integrity in menopause is distinctly different from aged menopause mice.Quantitative proteomics of ileum samples in premenopausal (n=5), menopausal (n=5), aged menopausal (n=5), and male mice (n=5) identified 7664 proteins with >1 unique peptide of which 134 proteins were significant (p<0.05) with a max fold change ˂1.27 across all groups. Protein expression of all groups was assessed using principal component analysis. Aged menopausal mice cluster closer to premenopausal mice than menopausal mice. These results indicate that changes in the ileum during menopause are different than those observed in aging. Compared to premenopausal mice, menopausal mice have significantly increased in proteins involved in the Go-biological processes including an enrichment in proteins involved in the innate immune system (6.3 fold enrichment, FE, -log10p=0.00006), phagocytosis recognition (19.82 FE, -log10p=1.14), defense response to bacterium (10.066 FE, -log10p=9.56), and B cell receptor signaling pathways (20.311 FE, -log10p=9.33). In contrast, male mice compared to premenopausal mice show a significant decrease in proteins involved in phagocytosis recognition (22.57 FE, -log10p=4.28), defense response to bacterium (12.898 FE, -log10p=2.76), and B cell receptor signaling pathway (20.56 FE, -log10p=8.12). These results indicate an increase in immune activity in menopausal female mice and a decrease in male mice compared to premenopausal female mice. In summary, these data demonstrate the change within the gut during menopause is dissimilar to those seen in male and aging mice. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

physiology
Additional File 1 of the Hindgut Microbiome Contributes to Host Oxidative Stress in Postpartum Dairy Cows by Affecting Glutathione Synthesis Process

Fengfei Gu,Senlin Zhu,Jiafa Hou,Yifan Tang,Jianxin Liu,Qingbiao Xu,Hui-Zeng Sun

DOI: https://doi.org/10.6084/m9.figshare.22679542

2023-01-01

Abstract:Additional file 1: Table S1. Ingredients of the basal diet (%, DM basis). Table S2. Summary of 16S rRNA gene sequencing data from fecal samples of 51 dairy cows. Table S3. The relative abundance of ASV generated by 16S rRNA sequencing in 51 cows. Table S4. The relative abundance of bactera in the feces of 51 cows at phylum, family and genus level. Table S5. Summary of sequence data generated from gut fecal samples of 9 LOS and 9 HOS cows. Table S6. The correlations of significantly the different microbiota and plasma OSI. Table S7. The renriched KEGG pathways (level3) in the gut of LOS cows and HOS cows. Table S8. The fecal metabolome profile of LOS and HOS cows. Table S9. The sources of the metabolites and differential analysis. Table S10. The enrichment analysis of the metabolites from microbiota, co-metabolism and host. Table S11. The correlation analysis between significant different microbiota and the major KEGG pathways. Table S12. Summary of identified KOEtries in the gut of LOS and HOS cows.
Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

Rui Liu,Chenhong Zhang,Yu Shi,Feng Zhang,Linxia Li,Xuejiao Wang,Yunxia Ling,Huaqing Fu,Weiping Dong,Jian Shen,Andrew Reeves,Andrew S. Greenberg,Liping Zhao,Yongde Peng,Xiaoying Ding

DOI: https://doi.org/10.3389/fmicb.2017.00324

IF: 5.2

2017-02-28

Frontiers in Microbiology

Abstract:Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women. Gut microbiota has been implicated to play a critical role in metabolic diseases and may modulate the secretion of mediators of the brain-gut axis. Interaction between gut microbiota and the endocrine and biochemical disturbances in PCOS still remains elusive. Here, we showed an altered gut microbiota significantly correlated with PCOS phenotype. There were 33 patients with PCOS (non-obese PCOS individuals, PN, n = 12; obese PCOS individuals, PO, n = 21) as well as 15 control subjects (non-obese control individuals, CN, n = 9; obese control individuals, CO, n = 6) enrolled in our study. The plasma levels of serotonin, ghrelin, and peptide YY (PYY) were significantly decreased in patients with PCOS compared with controls, and have a significantly negative correlation with waist circumference and testosterone. Sequencing of the V3-V4 region of the 16S rRNA gene in fecal samples revealed the substantial differences of gut microbial species between the PCOS and non-obese controls. Bacterial species were clustered into 23 co-abundance groups (CAGs) based on the SparCC correlation coefficients of their relative abundance. The CAGs increased in PCOS, including the bacteria belonging to Bacteroides, Escherichia/Shigella and Streptococcus, were negatively correlated with ghrelin, and positively correlated with testosterone and BMI. Furthermore, the CAGs that were decreased in PCOS, including the bacteria from Akkermansia and Ruminococcaceae, showed opposite relationship with body-weight, sex-hormone, and brain-gut peptides. In conclusion, gut microbial dysbiosis in women with PCOS is associated with the disease phenotypes.

microbiology
Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos

Brandilyn A Peters,Juan Lin,Qibin Qi,Mykhaylo Usyk,Carmen R Isasi,Yasmin Mossavar-Rahmani,Carol A Derby,Nanette Santoro,Krista M Perreira,Martha L Daviglus,Michelle A Kominiarek,Jianwen Cai,Rob Knight,Robert D Burk,Robert C Kaplan

DOI: https://doi.org/10.1128/msystems.00273-22

2022-06-28

mSystems

Abstract:Menopause is a pivotal period during which loss of ovarian hormones increases cardiometabolic risk and may also influence the gut microbiome. However, the menopause-microbiome relationship has not been examined in a large study, and its implications for cardiometabolic disease are unknown. In the Hispanic Community Health Study/Study of Latinos, a population with high burden of cardiometabolic risk factors, shotgun metagenomic sequencing was performed on stool from 2,300 participants (295 premenopausal women, 1,027 postmenopausal women, and 978 men), and serum metabolomics was available on a subset. Postmenopausal women trended toward lower gut microbiome diversity and altered overall composition compared to premenopausal women, while differing less from men, in models adjusted for age and other demographic/behavioral covariates. Differentially abundant taxa for post- versus premenopausal women included Bacteroides sp. strain Ga6A1, Prevotella marshii, and Sutterella wadsworthensis (enriched in postmenopause) and Escherichia coli-Shigella spp., Oscillibacter sp. strain KLE1745, Akkermansia muciniphila, Clostridium lactatifermentans, Parabacteroides johnsonii, and Veillonella seminalis (depleted in postmenopause); these taxa similarly differed between men and women. Postmenopausal women had higher abundance of the microbial sulfate transport system and decreased abundance of microbial β-glucuronidase; these functions correlated with serum progestin metabolites, suggesting involvement of postmenopausal gut microbes in sex hormone retention. In postmenopausal women, menopause-related microbiome alterations were associated with adverse cardiometabolic profiles. In summary, in a large U.S. Hispanic/Latino population, menopause is associated with a gut microbiome more similar to that of men, perhaps related to the common condition of a low estrogen/progesterone state. Future work should examine similarity of results in other racial/ethnic groups. IMPORTANCE The menopausal transition, marked by declining ovarian hormones, is recognized as a pivotal period of cardiometabolic risk. Gut microbiota metabolically interact with sex hormones, but large population studies associating menopause with the gut microbiome are lacking. Our results from a large study of Hispanic/Latino women and men suggest that the postmenopausal gut microbiome in women is slightly more similar to the gut microbiome in men and that menopause depletes specific gut pathogens and decreases the hormone-related metabolic potential of the gut microbiome. At the same time, gut microbes may participate in sex hormone reactivation and retention in postmenopausal women. Menopause-related gut microbiome changes were associated with adverse cardiometabolic risk in postmenopausal women, indicating that the gut microbiome contributes to changes in cardiometabolic health during menopause.
Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China

Gailing Li,Zhenguo Liu,Fang Ren,Huirong Shi,Qian Zhao,Yi Song,Xunjie Fan,Xiaojun Ma,Guijun Qin

DOI: https://doi.org/10.3389/fmicb.2022.911992

IF: 5.2

2022-07-01

Frontiers in Microbiology

Abstract:Objective: The purpose of this study was to elucidate the characteristics of the gut microbiome in patients with Polycystic ovary syndrome (PCOS) and analyze the alterations of fecal fatty acid metabolism, so as to further provide the pathogenesis of PCOS. Methods: Fecal samples from the PCOS group ( n = 31) and healthy control group ( n = 27) were analyzed by 16S rRNA gene sequencing and untargeted metabolomics. Peripheral venous blood was collected to measure serum inflammation and intestinal permeability. Finally, the correlation analysis of intestinal flora, fecal metabolites, and laboratory indicators was carried out. Results: Serum D-lactate content in the PCOS group was higher than that in the control group. There was no significant difference in microbial α diversity and β diversity between PCOS patients and healthy controls. Peptostreptococcaceae and Bacteroidales S24-7 group existed significant differences between PCOS patients and healthy controls. Based on linear discriminant analysis selection, 14 genera including Klebsiella , Enterobacteriaceae , and Gammaproteobacteria were dominant in patients with PCOS, while 4 genera, including rumenococcus ( Ruminocaccaceae UCG 013 ), prewortella ( Prevotellaceae UCG 001 ), and erysipelas ( Erysipelatoclostridium ), were dominant in healthy controls. Compared with PCOS with Body mass index (BMI) < 24, patients with BMI ≥ 24 have multiple dominant genera including Abiotrophia and Peptostreptococcaceae . Moreover, serum levels of free testosterone and androstenedione were positively correlated with Megamonas , while total testosterone was negatively correlated with Alistipes . Additionally, fecal contents of acetic acid and propionic acid in patients with PCOS were significantly higher than those in healthy controls. Eubacterium_coprostanoligenes_group and Alistipes were positively correlated with 6 kinds of fatty acids. Conclusion: Specific intestinal flora fecal fatty acids and serum metabolites may mediate the occurrence and development of PCOS. PCOS patients with different body sizes have specific intestinal flora.

microbiology
Metagenomic Analysis Identified Microbiome Alterations and Pathological Association Between Intestinal Microbiota and Polycystic Ovary Syndrome

Weiwei Chu,Qixin Han,Jieying Xu,Juan Wang,Yun Sun,Weiping Li,Zi-Jiang Chen,Yanzhi Du

DOI: https://doi.org/10.2139/ssrn.3422975

2019-01-01

SSRN Electronic Journal

Abstract:Objective: To identify different microbial species in women with polycystic ovary syndrome (PCOS) and reveal a possible relationship between gut dysbiosis and pathological changes. Design: Cross-sectional study. Setting: Academic institution. Patient(s): Reproductive-aged women with PCOS (n = 14) and controls (n = 14) from the Centre for Reproductive Medicine. Intervention(s): Shotgun metagenomic sequencing on fecal samples from patients, and clinical parameters (including body mass index, endocrine hormone levels, and glycemia level) gathered for correlation analysis. Main Outcome Measure(s): Identification of different gut microbial strains and relativity between microbiota and clinical parameters. Result(s): We found several microbial strains were statistically significantly more abundant in the PCOS group, including Parabacteroides merdae, Bacteroides fragilis, and strains of Escherichia and Shigella, whereas Faecalibacterium prausnitzii was enriched in the control group. Metagenomic species (MGS) analysis revealed that the microbes of the PCOS group were negatively correlated with those of the control group. Of note, we observed a positive correlation between MGS relevant to PCOS and endocrine disorders, including body mass index and elevated levels of serum testosterone, luteinizing hormone, and antimullerian hormone. Functional alterations, reflected by Kyoto Encyclopedia of Genes and Genomes orthologues, could imply potential mechanisms of microbial involvement in the developmental progress of PCOS. Conclusion(s): Our findings suggest an intimate association and potential mechanisms linking microbial dysbiosis and the pathophysiologic changes of PCOS. We address the importance of monitoring and modulating microbial composition and functional shifts in future clinical practice. ((C) 2020 by American Society for Reproductive Medicine.)
Alterations of Gut Microbiota Biodiversity and Relative Abundance in Women with PCOS: A Systematic Review and Meta-Analysis

Yuanyuan Zou,Ruyi Liao,Rui Cheng,Hyun Cheol Chung,Honglin Zhu,Yefang Huang

DOI: https://doi.org/10.1016/j.micpath.2023.106370

IF: 3.848

2023-01-01

Microbial Pathogenesis

Abstract:Numerous studies have implicated that the gut microbiota is associated with polycystic ovary syndrome (PCOS). However, a comprehensive data-based summary shown that the effects of the PCOS on the gut microbiota is minimal. We aim to assess the alterations of gut microbiota in women with PCOS. An electronic search of PubMed, Web of Science, Embase, Cochrane Library and Ovid was conducted for eligible studies published from inception to 28 March 2023, without any language or regional restrictions. We used Newcastle-Ottawa Quality Assessment Scale (NOS) to complete the assessment of the risk of bias and Stata 15.1 software to performed meta-analysis. There were 19 human observational studies in total with 617 women with PCOS and 439 healthy individuals were identified. Compared to the control group, the Chao index (WMD -28.88, 95% CI -45.78 to −11.98, I2 = 100%), Shannon index (WMD -0.11, 95% CI -0.18 to 0.00, I2 = 92.2%); and observed operational taxonomic units (OTUs) counts (WMD - 23.48, 95% CI -34.44 to −12. 53, I2 = 99.6%) were significantly lower in women with PCOS. The relative abundance of Bacteroidaceae was significantly higher (WMD 0.12, 95% CI 0.02 to 0.22, I2 = 9.2%), however there were no statistical differences in Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, Alcaligenaceae, Bifidobacteriaceae, Clostridiaceae, Enterobacteriaceae, Lachnospiraceae, Prevotellaceae, Ruminococcaceae, Veillonellaceae, Bacteroides, Bifidobacterium, Blautia, Dialister, Escherichia-Shigella, Faecalibacterium, Lachnoclostridium, Lachnospira, Megamonas, Phascolarctobacterium, Prevotella, Roseburia, and Subdoligranulum. We demonstrated the alpha diversity of gut microbiota and the relative abundance of Bacteroidaceae in women with PCOS are altered. The results indicates that dysbiosis may be a potential pathogenetic factor in PCOS and provided reliable information to investigate the role of gut microbiota in the development and progression of PCOS.
Integrated metagenome and metabolome analyses of blood pressure studies in early postmenopausal Chinese women

Hui-Min Liu,Xu Lin,Xiang-He Meng,Qi Zhao,Jie Shen,Hong-Mei Xiao,Hong-Wen Deng

DOI: https://doi.org/10.1097/hjh.0000000000002832

IF: 4.9

2021-03-19

Journal of Hypertension

Abstract:OBJECTIVE: We carried out sensitivity analyses on gut microbiota metagenomic sequencing, untargeted metabolome, targeted metabolome for short-chain fatty acids (SCFAs) and human whole genome sequencing from 402 early postmenopausal Chinese women to search for early omics-biomarkers and gain novel insights into the potential mechanisms of BP regulation in postmenopausal women.METHODS: Clusters of co-abundant gut bacterial species and serum untargeted metabolites were identified by weighted gene co-expression network analysis (WGCNA). Partial least square analysis and joint analysis were performed to detect BP-associated omics-variables. Partial Pearson correlation was conducted to identify the interactions of microbe--host for host BP variation. Mendelian randomization analysis and causal inference test were used to examine causal relationships among gut microbiota, metabolites and BP variation.RESULTS: In the present study, 651 bacterial species and 296 metabolites were binned into 53 and 26 co-abundance clusters by WGCNA, respectively. Then, we totally identified four gut bacterial species, one host metabolites and two SCFAs that were significantly associated with both SBP and DBP. Moreover, we found that gut microbiota would play important roles in host metabolic activity. Finally, our results revealed that increased Bacteroides fragilis could elevate BP via decreased caproic acid, and phenylacetylglutamine mediated the causal relationships of both B. fragilis and Clostridium sp.CAG.226 on DBP variation.CONCLUSION: Multi-omics datasets integration has the potential to capture complementary effect and their interactions for BP variation, revealed the potential pathogenesis of BP variation and may be useful for studying other complex diseases/traits.

peripheral vascular disease
Gut Microbe-Metabolite Profiles Are Associated with Microbial Pathways of Longevity in Women: A Cross-Sectional Study Conducted in China

Qinren Zhang,Ning Meng,Ruiding Li,Qianzu He,Xiaolin Liang,Fan Zhou,Wenxuan Zheng,Jinke Ma,Xiaohan Yu,Kaiyan Tan,Quanyang Li

DOI: https://doi.org/10.1159/000534681

2023-10-26

Gerontology

Abstract:Introduction: Recent research on the gut deepens people’s understanding of the role of gut microbe-metabolites in longevity. However, most of the longevity population is female, and the gut microbe-metabolites associated with longevity in women remain unknown. Here, we hypothesize that the gut microbe-metabolite levels differed between the longevity women (LW, age ≥90) and the elderly women (EW, 60 < age <90). Methods: We performed a cross-sectional study of 22 women in Guangxi longevity areas. 16S rRNA full-length sequencing, bioinformatic analysis, and nuclear magnetic resonance hydrogen spectra were determined to analyze the gut microbiota, microbial pathways, and fecal metabolites. We evaluated significant differences and relationships in gut microbe-metabolites and microbial pathways using the Mann-Whitney test and Spearman correlation, respectively. Results: The EW experienced gut dysbiosis characterized by a higher Firmicutes/Bacteroidetes (F/B) value. The LW showed a higher abundance of Bacteroides and Alistipes , which might support health maintenance. Moreover, LW enriched alanine, aspartate, and glutamate metabolism, histidine metabolism, and pyruvate metabolism, leading to major changes in histidine, fumaric acid, acetate, valine, and aspartate. Interestingly, the most valuable metabolic pathway based on differential fecal metabolites confirmed the KEGG microbial pathway “alanine, aspartate, and glutamate metabolism” enriched in LW. Impressively, Bacteroides and Alistipes were positively correlated with alanine, aspartate, and glutamate metabolism, thus improving the level of aspartate, which could be a particular pathway related to longevity. Conclusion: The enriched gut genus and microbial pathways in LW showed a significant correlation, which might mediate the production of metabolites related to longevity.

geriatrics & gerontology,gerontology

Additional File 4 of the Relationship Between Menopausal Syndrome and Gut Microbes

The Relationship Between Menopausal Syndrome and Gut Microbes

Additional File 5 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Additional File 3 of Vegetarian Diet Duration’s Influence on Women’s Gut Environment

Systematic Review and Meta-analysis: Changes of Gut Microbiota before and after Menopause

Additional File 8 of Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Study on gut microbiota and metabolomics in postmenopausal women

The Menopause-Related Gut Microbiome: Associations with Metabolomics, Inflammatory Protein Markers, and Cardiometabolic Health in Women with HIV.

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Integrated analysis of metabolome and microbiome in a rat model of perimenopausal syndrome

Additional File 2: of Linking Gut Microbiota, Metabolic Syndrome and Economic Status Based on a Population-Level Analysis

Vaginal microbiota, menopause, and the use of menopausal hormone therapy: a cross-sectional, pilot study in Chinese women

Sex, age and menopause differentially impact gut barrier function and proteomic profile

Additional File 1 of the Hindgut Microbiome Contributes to Host Oxidative Stress in Postpartum Dairy Cows by Affecting Glutathione Synthesis Process

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos

Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China

Metagenomic Analysis Identified Microbiome Alterations and Pathological Association Between Intestinal Microbiota and Polycystic Ovary Syndrome

Alterations of Gut Microbiota Biodiversity and Relative Abundance in Women with PCOS: A Systematic Review and Meta-Analysis

Integrated metagenome and metabolome analyses of blood pressure studies in early postmenopausal Chinese women

Gut Microbe-Metabolite Profiles Are Associated with Microbial Pathways of Longevity in Women: A Cross-Sectional Study Conducted in China